CD4 and rheumatoid arthritis: Determining if FLS can present antigen on MHC class II and stimulate CD4+ T cells in vivo and thereby serve as nontraditional professional antigen-presenting cells may reveal important information regarding inflammation in RA, because it would reveal FLS as an in situ activator of T cells at a site of inflammation.